Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Skin cancer, nonmelanomatous (squamous and basal cell)
Trial Type:  Treatment
Results 1-11 of 11 for your search:
Start Over
A Study in Advanced Solid Tumors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13420, NCI-2012-01213, I4E-MC-JXBB, NCT01063075
Biomarkers in Tissue Samples From Patients With Basal Cell Skin Cancer Treated With Itraconazole
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: SKIN0004, NCI-2011-00419, 17365, NCT01108094
Docetaxel, Cisplatin, and Cetuximab in Treating Patients With Metastatic or Relapsed Head and Neck Cancer
Phase: Phase II
Type: Treatment
Age: 16 and over
Trial IDs: ENT0033, NCI-2011-03271, 22329, SU-08222011-8290, NCT01437449
Radiation Therapy and Vismodegib in Treating Patients With Locally Advanced Head and Neck Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CC #122011, NCI-2013-00871, 122011, NCT01835626
Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients with Basal Cell Nevus Syndrome
Phase: Phase II
Type: Supportive care, Treatment
Age: Any age
Trial IDs: CASE 2614, NCI-2014-02037, NCT02157623
Peginterferon Alfa-2b and Capecitabine in Treating Patients with Skin Cancer That Is Metastatic or Cannot Be Removed by Surgery
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: MCC 17759, NCI-2014-01864, 14.06.0011, NCT02218164
Stereotactic Radiosurgery in Treating Patients with Oligometastatic Disease
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10-027, NCI-2014-01952, REN13120042, UPCI #10-027, NCT01345539
Stereotactic Radiosurgery in Treating Patients with Oligo-Recurrent Disease
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10-028, NCI-2014-01953, REN13120040, UPCI# 10-028, NCT01345552
Erismodegib in Treating Patients With Locally Advanced or Metastatic Basal Cell Skin Cancer Who Previously Received Smo Inhibitor Treatment
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: SKIN0009, NCI-2012-00042, 21759, NCT01529450
Itraconazole in Treating Patients with Basal Cell Carcinoma
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: J1299, NCI-2014-01255, NA_00077461, NCT02120677
Electronic Skin Surface Brachytherapy in Treating Older Patients with Newly Diagnosed Early Stage Basal Cell or Squamous Cell Skin Cancer
Phase: No phase specified
Type: Treatment
Age: 60 and over
Trial IDs: 14-001, NCI-2014-01090, NCT02131805
Start Over